- Dec 17, 2019
- London, ON
In that case - yeah, it's pretty good at what it does. My experience with Rexulti seems to match up with teh Abilify results.Wikipedia says Brexpiprazole was, "developed by Otsuka and Lundbeck, and is considered to be a successor of Otsuka's top-selling atypical antipsychotic aripiprazole (Abilify). Otsuka's U.S. patent on aripiprazole expired on October 20, 2014; and a generic was approved in April, 2015.".
I don't think Brexpiprazole is available here in the UK.
It's actually kind of expensive here, because it's new.